Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Pimco High Income Fund (PHK), Annaly Capital Management, Inc. (NLY): Bonds – We’ve Seen This Movie Before. It Doesn’t End Well

Investors have short memories. Our recollections about five years ago are hazy. Ten years, and lessons are forgotten. Thirty years ago might as well have been the Big Bang.

Some New ETFs Could be Stars in 2013Bonds have been in a 30-year bull market, so even some of the most grizzled professionals haven’t experienced a prolonged period of pain. But history doesn’t forget. The bond market has been here before. And it didn’t end well.

Interest rates were kept incredibly low in the 1940s and 1950s to help manage the national debt after World 2. Ten-year Treasury bonds yield almost the exact same today as they did in 1950.

What happened to Treasuries after that? Those who held to maturity received their principal back. But inflation eroded all of the value of interest payments, and then some. And as interest rates rose in the 1970s, the value of existing bonds plunged. The result in real (inflation-adjusted) terms was three decades of sheer misery:

Average annual real returns

Period 10-Year Treasuries 30-Year Treasuries Corporate Bonds
1950-1959 (1.80%) (2.67%) (2.02%)
1960-1969 0.23% (1.96%) (1.90%)
1970-1979 (1.19%) (3.40%) (1.88%)

Source: Deutsche Bank Long-Term Asset Return Study.

These losses might seem small, but they add up fast. $100 invested in 10-year Treasury bonds lost 40% of its value in real terms by the early 1980s:

Source: NYU, Federal Reserve, author’s calculations.

Inflation was out of control in the 1970s and early 1980s — that wasn’t a normal period by any means. But even before the inflation spike, those who purchased Treasuries in 1950s went 20 years without earning a penny in real terms. That’s what you get for buying when rates are so low.

Short-term bonds might still make sense for those who need ready access to their money. For all else, the last century gives us a reasonable set of expectations going forward: Bonds are possibly a way to maintain the value of your assets, almost certainly not a way to grow them, and potentially a way to lose a lot of them.

Interest rates have risen over the last month, offering a taste. Pimco High Income Fund (NYSE:PHK) is down 10% in the last month. The Vanguard Long Term Corporate Bond Fund lost 4.6%. Mortgage REITS sensitive to the same interest rate risk have been pummeled; Annaly Capital Management, Inc. (NYSE:NLY) shares are off by one-fifth over the last year.

How bad can this get? It can’t be stressed enough that we have no idea. Many investors thought Japanese bonds were toast in the early 1990s. Twenty years and dozens of ruined careers later, we’re still waiting for the crash.

But when interest rates are this low, the best-case scenario becomes not getting hurt, and getting hurt becomes pretty likely.

The article Bonds: We’ve Seen This Movie Before. It Doesn’t End Well originally appeared on Fool.com.

Fool contributor Morgan Housel has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!